Genome-wide studies have identified new genes involved in susceptibility to melanoma
The results are published in 2 Nature Genetics papers involving investigators from IDIBAPS -- Hospital Clínic of Barcelona
The genomic analysis technologies enable the study of genetic factors related to numerous diseases. In few areas this researches brought such a big and useful volume of information as in the case of melanoma.
A study published in Nature Genetics, promoted by the GenoMEL consortium, consolidates the results obtained in previous whole-genome analysis and identifies three new chromosomal regions implicated in susceptibility to melanoma. The GenoMEL consortium is funded by the European Commission and the National Institutes of Health (USA) to increase the understanding of genetic and molecular determinants of melanoma. Researchers at the Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and the Hospital Clínic of Barcelona have a relevant role among the promoters of this consortium led by the University of Leeds. Dr. Susana Puig leads the research team, formed by many experts as Dr. Josep Malvehy or Dr. Joan Anton Puig, and appears as an author in this Nature Genetics paper as well as in another one led from Australia. This team is supported by the CIBER of Rare Diseases (CIBERER) funded by the Spanish Ministry of Science and Innovation.
The conclusions of the European study revalidate regions and genes already identified as significant for melanoma in previous works. Thus the role of genes related to cell cycle as CDKN2A or CDK4, and other related aspects such as hair and eye pigmentation, is reinforced by the new data. The results identify too three new correlations with the risk of melanoma, located in different parts of the genome. On chromosome 2 investigators underline the role of Caspase 8, a gene related to programmed cell death or apoptosis; on chromosome 11 they localized ATM gene, linked to DNA repair, a necessary process specially after sunlight harmful effects overexposure; finally, the surprise was located on chromosome 21, where the MX2 gene was associated for the very first time with cancer and should be studied more carefully to understand its role.
The Australian work identified a large area of chromosome 1 rich with genes that might also be associated with melanoma. The relevance of these two works, both with the participation of researchers from IDIBAPS - Hospital Clínic, is reinforced by the fact that the results have been validated both in the European and Australian populations. Thus, the identified genes are relevant to the disease regardless of the population under study. Researchers face a complex puzzle, where environmental factors also play an important role. These data should aid studies aimed at designing new diagnostic and prognostic tools to make possible new treatments as well as to strengthen existing genetic counseling and diagnostic strategies.
For further information:
Institut D'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS)
Àlex Argemí (firstname.lastname@example.org)
Tel: +34 93 227 57 00
Alex Argemi | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Mapping the interaction of a single atom with a single photon may inform design of quantum devices
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...